Literature DB >> 31732108

Mechanisms Underlying the Hyperexcitability of CA3 and Dentate Gyrus Hippocampal Neurons Derived From Patients With Bipolar Disorder.

Shani Stern1, Anindita Sarkar2, Tchelet Stern2, Arianna Mei2, Ana P D Mendes2, Yam Stern2, Gabriela Goldberg2, Dekel Galor2, Thao Nguyen2, Lynne Randolph-Moore2, Yongsung Kim2, Guy Rouleau3, Anne Bang4, Martin Alda5, Renata Santos6, Maria C Marchetto2, Fred H Gage7.   

Abstract

BACKGROUND: Approximately 1 in every 50 to 100 people is affected with bipolar disorder (BD), making this disease a major economic burden. The introduction of induced pluripotent stem cell methodology enabled better modeling of this disorder.
METHODS: Having previously studied the phenotype of dentate gyrus granule neurons, we turned our attention to studying the phenotype of CA3 hippocampal pyramidal neurons of 6 patients with BD compared with 4 control individuals. We used patch clamp and quantitative polymerase chain reaction to measure electrophysiological features and RNA expression by specific channel genes.
RESULTS: We found that BD CA3 neurons were hyperexcitable only when they were derived from patients who responded to lithium; they featured sustained activity with large current injections and a large, fast after-hyperpolarization, similar to what we previously reported in dentate gyrus neurons. The higher amplitudes and faster kinetics of fast potassium currents correlated with this hyperexcitability. Further supporting the involvement of potassium currents, we observed an overexpression of KCNC1 and KCNC2 in hippocampal neurons derived from lithium responders. Applying specific potassium channel blockers diminished the hyperexcitability. Long-term lithium treatment decreased the hyperexcitability observed in the CA3 neurons derived from lithium responders while increasing sodium currents and reducing fast potassium currents. When differentiating this cohort into spinal motor neurons, we did not observe any changes in the excitability of BD motor neurons compared with control motor neurons.
CONCLUSIONS: The hyperexcitability of BD neurons is neuronal type specific with the involvement of altered potassium currents that allow for a sustained, continued firing activity.
Copyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Dentate gyrus; Hippocampus; Hyperexcitability; Motor neurons; Pyramidal

Mesh:

Substances:

Year:  2019        PMID: 31732108      PMCID: PMC7108962          DOI: 10.1016/j.biopsych.2019.09.018

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  43 in total

1.  Modulation of excitability by alpha-dendrotoxin-sensitive potassium channels in neocortical pyramidal neurons.

Authors:  J M Bekkers; A J Delaney
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder.

Authors:  Stephen M Strakowski; Melissa P DelBello; Molly E Zimmerman; Glen E Getz; Neil P Mills; Jennifer Ret; Paula Shear; Caleb M Adler
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

3.  Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis.

Authors:  Tomas Hajek; Miloslav Kopecek; Cyril Höschl; Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2012-09       Impact factor: 6.186

4.  Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells.

Authors:  Maria C N Marchetto; Alysson R Muotri; Yangling Mu; Alan M Smith; Gabriela G Cezar; Fred H Gage
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

5.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

Authors:  Kathleen R Merikangas; Hagop S Akiskal; Jules Angst; Paul E Greenberg; Robert M A Hirschfeld; Maria Petukhova; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2007-05

6.  Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder.

Authors:  Jerome Mertens; Qiu-Wen Wang; Yongsung Kim; Diana X Yu; Son Pham; Bo Yang; Yi Zheng; Kenneth E Diffenderfer; Jian Zhang; Sheila Soltani; Tameji Eames; Simon T Schafer; Leah Boyer; Maria C Marchetto; John I Nurnberger; Joseph R Calabrese; Ketil J Ødegaard; Michael J McCarthy; Peter P Zandi; Martin Alda; Martin Alba; Caroline M Nievergelt; Shuangli Mi; Kristen J Brennand; John R Kelsoe; Fred H Gage; Jun Yao
Journal:  Nature       Date:  2015-10-28       Impact factor: 49.962

7.  Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.

Authors: 
Journal:  Nat Genet       Date:  2011-09-18       Impact factor: 38.330

8.  The influence of lithium on hippocampal volume in elderly bipolar patients: a study using voxel-based morphometry.

Authors:  S Zung; F L Souza-Duran; M G Soeiro-de-Souza; R Uchida; C M Bottino; G F Busatto; H Vallada
Journal:  Transl Psychiatry       Date:  2016-06-28       Impact factor: 6.222

9.  Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.

Authors:  D P Hibar; L T Westlye; N T Doan; N Jahanshad; J W Cheung; C R K Ching; A Versace; A C Bilderbeck; A Uhlmann; B Mwangi; B Krämer; B Overs; C B Hartberg; C Abé; D Dima; D Grotegerd; E Sprooten; E Bøen; E Jimenez; F M Howells; G Delvecchio; H Temmingh; J Starke; J R C Almeida; J M Goikolea; J Houenou; L M Beard; L Rauer; L Abramovic; M Bonnin; M F Ponteduro; M Keil; M M Rive; N Yao; N Yalin; P Najt; P G Rosa; R Redlich; S Trost; S Hagenaars; S C Fears; S Alonso-Lana; T G M van Erp; T Nickson; T M Chaim-Avancini; T B Meier; T Elvsåshagen; U K Haukvik; W H Lee; A H Schene; A J Lloyd; A H Young; A Nugent; A M Dale; A Pfennig; A M McIntosh; B Lafer; B T Baune; C J Ekman; C A Zarate; C E Bearden; C Henry; C Simhandl; C McDonald; C Bourne; D J Stein; D H Wolf; D M Cannon; D C Glahn; D J Veltman; E Pomarol-Clotet; E Vieta; E J Canales-Rodriguez; F G Nery; F L S Duran; G F Busatto; G Roberts; G D Pearlson; G M Goodwin; H Kugel; H C Whalley; H G Ruhe; J C Soares; J M Fullerton; J K Rybakowski; J Savitz; K T Chaim; M Fatjó-Vilas; M G Soeiro-de-Souza; M P Boks; M V Zanetti; M C G Otaduy; M S Schaufelberger; M Alda; M Ingvar; M L Phillips; M J Kempton; M Bauer; M Landén; N S Lawrence; N E M van Haren; N R Horn; N B Freimer; O Gruber; P R Schofield; P B Mitchell; R S Kahn; R Lenroot; R Machado-Vieira; R A Ophoff; S Sarró; S Frangou; T D Satterthwaite; T Hajek; U Dannlowski; U F Malt; V Arolt; W F Gattaz; W C Drevets; X Caseras; I Agartz; P M Thompson; O A Andreassen
Journal:  Mol Psychiatry       Date:  2017-05-02       Impact factor: 15.992

10.  Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells.

Authors:  Joana Frobel; Hatim Hemeda; Michael Lenz; Giulio Abagnale; Sylvia Joussen; Bernd Denecke; Tomo Sarić; Martin Zenke; Wolfgang Wagner
Journal:  Stem Cell Reports       Date:  2014-08-14       Impact factor: 7.765

View more
  6 in total

1.  Prenatal dexamethasone exposure induces anxiety- and depressive-like behavior of male offspring rats through intrauterine programming of the activation of NRG1-ErbB4 signaling in hippocampal PV interneurons.

Authors:  Shuai Zhang; Shuwei Hu; Wanting Dong; Songqiang Huang; Zhexiao Jiao; Zewen Hu; Shiyun Dai; Yiwen Yi; Xiaohan Gong; Ke Li; Hui Wang; Dan Xu
Journal:  Cell Biol Toxicol       Date:  2021-06-29       Impact factor: 6.691

2.  Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants.

Authors:  Niklas Schwarz; Simone Seiffert; Manuela Pendziwiat; Annika Verena Rademacher; Tobias Brünger; Ulrike B S Hedrich; Paul B Augustijn; Hartmut Baier; Allan Bayat; Francesca Bisulli; Russell J Buono; Ben Zeev Bruria; Michael G Doyle; Renzo Guerrini; Gali Heimer; Michele Iacomino; Hugh Kearney; Karl Martin Klein; Ioanna Kousiappa; Wolfram S Kunz; Holger Lerche; Laura Licchetta; Ebba Lohmann; Raffaella Minardi; Marie McDonald; Sarah Montgomery; Lejla Mulahasanovic; Renske Oegema; Barel Ortal; Savvas S Papacostas; Francesca Ragona; Tiziana Granata; Phillip S Reif; Felix Rosenow; Annick Rothschild; Paolo Scudieri; Pasquale Striano; Paolo Tinuper; George A Tanteles; Annalisa Vetro; Felix Zahnert; Ethan M Goldberg; Federico Zara; Dennis Lal; Patrick May; Hiltrud Muhle; Ingo Helbig; Yvonne Weber
Journal:  Neurology       Date:  2022-03-21       Impact factor: 11.800

3.  Lithium use associated with symptom severity in comorbid bipolar disorder I and migraine.

Authors:  Nicole M Sekula; Anastasia K Yocum; Steven Anderau; Melvin G McInnis; David F Marshall
Journal:  Brain Behav       Date:  2022-05-05       Impact factor: 3.405

4.  Emerging evidence of genotype-phenotype associations of developmental and epileptic encephalopathy due to KCNC2 mutation: Identification of novel R405G.

Authors:  Sumei Wang; Yejing Yu; Xu Wang; Xiaolong Deng; Jiehui Ma; Zhisheng Liu; Weiyue Gu; Dan Sun
Journal:  Front Mol Neurosci       Date:  2022-08-25       Impact factor: 6.261

Review 5.  Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders.

Authors:  Jack T Whiteley; Sarah Fernandes; Amandeep Sharma; Ana Paula D Mendes; Vipula Racha; Simone K Benassi; Maria C Marchetto
Journal:  Stem Cell Reports       Date:  2022-01-20       Impact factor: 7.294

6.  Circadian rhythms in bipolar disorder patient-derived neurons predict lithium response: preliminary studies.

Authors:  Himanshu K Mishra; Noelle M Ying; Angelica Luis; Heather Wei; Metta Nguyen; Timothy Nakhla; Sara Vandenburgh; Martin Alda; Wade H Berrettini; Kristen J Brennand; Joseph R Calabrese; William H Coryell; Mark A Frye; Fred H Gage; Elliot S Gershon; Melvin G McInnis; Caroline M Nievergelt; John I Nurnberger; Paul D Shilling; Ketil J Oedegaard; Peter P Zandi; John R Kelsoe; David K Welsh; Michael J McCarthy
Journal:  Mol Psychiatry       Date:  2021-03-05       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.